Roni Mamluk
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Roni Mamluk currently works at RedHill Biopharma Ltd., as Independent Director from 2024 and Israel Biotech Fund, as Venture Advisor.
Dr. Mamluk also formerly worked at Old Ayala, Inc., as President, Chief Executive Officer & Director, Chiasma, Inc., as Independent Director from 2017 to 2021, Chiasma (Israel) Ltd., as Director from 2017 to 2021, Amryt Pharma Holdings Ltd., as Non-Executive Director, Amryt Pharma Ltd., as Non-Executive Director from 2021 to 2023, and Adnexus, as Head-Non Clinical Research & Development.
Dr. Mamluk received her undergraduate degree and doctorate degree from The Hebrew University of Jerusalem and graduate degree in 2004 from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REDHILL BIOPHARMA LTD. 0,05 % | 27/04/2026 | 28.120.000 ( 0,05 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Director/Miembro de la Junta | 01/09/2024 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Consultor / Asesor | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ADVAXIS, INC. | Director Ejecutivo | 19/01/2023 |
| AMRYT PHARMA PLC | Director/Miembro de la Junta | 01/01/2023 |
Chiasma (Israel) Ltd. | Director/Miembro de la Junta | 01/08/2021 |
| CHIASMA, INC. | Director Ejecutivo | 17/06/2015 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiasma (Israel) Ltd. | |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Old Ayala, Inc.
Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.